Transcutaneous vagus nerve stimulation (t-VNS): A novel effective treatment for temper outbursts in adults with Prader-Willi Syndrome indicated by results from a non-blind study

• Published in: PloS one 2019-12, Vol.14 (12), p.e0223750-e0223750
• Main Authors: Manning, Katherine E, Beresford-Webb, Jessica A, Aman, Lucie C S, Ring, Howard A, Watson, Peter C, Porges, Stephen W, Oliver, Chris, Jennings, Sally R, Holland, Anthony J
• Format: Article
• Language: English
• Subjects: Adult; Adults; Anger; Behavior disorders; Biology and Life Sciences; Care and treatment; Clinical trials; Cognition & reasoning; Convulsions & seizures; Design modifications; Epilepsy; Ethics; Female; Humans; Intervention; Male; Males; Medicine and health sciences; Nervous system; Neurodevelopmental disorders; Outbursts; Parasympathetic nervous system; Prader-Willi syndrome; Prader-Willi Syndrome - therapy; Psychiatry; Quality of life; Questionnaires; Self Report; Social Sciences; Statistical analysis; Stimulation; Studies; Surveys and Questionnaires; Temperament; Transcutaneous Electric Nerve Stimulation - methods; Treatment Outcome; Vagus nerve; Vagus Nerve - physiology; Vagus Nerve Stimulation - methods
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0223750

Temper outbursts are a severe problem for people with Prader-Willi Syndrome (PWS). Previous reports indicate that vagus nerve stimulation (VNS) may reduce maladaptive behaviour in neurodevelopmental disorders, including PWS. We systematically investigated the effectiveness of transcutaneous VNS (t-VNS) in PWS. Using a non-blind single case repeat measures modified ABA design, with participants as their own controls, t-VNS was evaluated in five individuals with PWS [three males; age 22-41 (M = 26.8)]. After a baseline phase, participants received four-hours of t-VNS daily for 12 months, followed by one month of daily t-VNS for two-hours. The primary outcome measure was the mean number of behavioural outbursts per day. Secondary outcomes included findings from behavioural questionnaires and both qualitative and goal attainment interviews. Four of the five participants who completed the study exhibited a statistically significant reduction in number and severity of temper outbursts after approximately nine months of daily four-hour t-VNS. Subsequent two-hour daily t-VNS was associated with increased outbursts for all participants, two reaching significance. Questionnaire and interview data supported these findings, the latter indicating potential mechanisms of action. No serious safety issues were reported. t-VNS is an effective, novel and safe intervention for chronic temper outbursts in PWS. We propose these changes are mediated through vagal projections and their effects both centrally and on the functioning of the parasympathetic nervous system. These findings challenge our present biopsychosocial understanding of such behaviours suggesting that there is a single major mechanism that is modifiable using t-VNS. This intervention is potentially generalizable across other clinical groups. Future research should address the lack of a sham condition in this study along with the prevalence of high drop out rates, and the potential effects of different stimulation intensities, frequencies and pulse widths.